The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 08, 2022

Filed:

Mar. 29, 2018
Applicant:

Fruithy Holdings Limited, Hong Kong, CN;

Inventors:

Shanchun Zhang, Anhui Province, CN;

Jiashi Peng, Anhui Province, CN;

Bin Yang, Anhui Province, CN;

Yihua Wang, Anhui Province, CN;

Min Xu, Anhui Province, CN;

Xiao Wang, Anhui Province, CN;

Kaisheng Cheng, Anhui Province, CN;

Assignee:

Fruithy Holdings Limited, Hong Kong, CN;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 47/54 (2017.01); A61K 31/52 (2006.01); A61K 31/505 (2006.01); A61K 31/573 (2006.01); A61K 31/4035 (2006.01); A61K 31/4164 (2006.01); A61P 1/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01); A61K 9/48 (2006.01); A61K 31/4468 (2006.01);
U.S. Cl.
CPC ...
A61K 47/549 (2017.08); A61K 9/167 (2013.01); A61K 9/1611 (2013.01); A61K 9/1652 (2013.01); A61K 9/2009 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/284 (2013.01); A61K 9/2813 (2013.01); A61K 9/2846 (2013.01); A61K 9/485 (2013.01); A61K 9/4825 (2013.01); A61K 9/4858 (2013.01); A61K 9/4866 (2013.01); A61K 31/4035 (2013.01); A61K 31/4164 (2013.01); A61K 31/4468 (2013.01); A61K 31/505 (2013.01); A61K 31/52 (2013.01); A61K 31/573 (2013.01); A61P 1/00 (2018.01);
Abstract

The present disclosure relates to the field of pharmaceutical chemistry, and particularly to a compound represented by Formula (I), a preparation method and medical use thereof. In the compound represented by Formula (I), a lactulosyl group is connected to a heteroatom of genin (G) via a glycosidic bond, wherein the genin (G) is a group formed by removing one hydrogen atom from a heteroatom of an active pharmaceutical molecule, and '' indicates that the lactulosyl group is connected to the heteroatom of the genin (G) via an α-glycosidic bond or a β-glycosidic bond. Pharmacokinetic experiments prove that the lactuloside compound according to the present disclosure can pass through the gastrointestinal tract of a mammal without being absorbed significantly by the gastrointestinal tract and hydrolyzed significantly by endogenous enzymes of a mammal host. Therefore, the lactuloside compound can arrive at the colon site of the mammal, and release an active drug in the colon under the action of colon flora. The lactuloside compound has a function of colon-localized drug release, and can be used for preventing or treating an intestinal disease.


Find Patent Forward Citations

Loading…